However, HIF1α also exerts tumor suppressive effects in glial cells (8), and (R)-2HG has been shown to stimulate HIF1α degradation as part of the oncogenic program associated with IDH mutations in glioma (9, 10). The gene discussed is IDH2; the disease is central nervous system cancer.